Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Haidian District, No. 10 Tieyi Road, Yangfangdian Street, Beijing, 100038, China.
Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Peking University Ninth School of Clinical Medicine, Beijing, 100038, China.
BMC Cancer. 2023 Sep 26;23(1):903. doi: 10.1186/s12885-023-11404-1.
Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) is the standard treatment for pseudomyxoma peritonei (PMP). It can significantly prolong the survival of patients, but at the same time may increase the risk of postoperative infection.
Patients with PMP who underwent CRS + HIPEC at our center were retrospectively analyzed. According to PMP patients, basic clinical data and relevant information of postoperative infection, we analyzed the common sites of postoperative infection, results of microbial culture and the antibiotics sensitivity. Univariate and multivariate analysis were performed to explore infection-related risk factors.
Among the 482 patients with PMP, 82 (17.0%) patients were infected after CRS + HIPEC. The most common postoperative infection was central venous catheter (CVC) infection (8.1%), followed by abdominal-pelvic infection (5.2%). There were 29 kinds of microbes isolated from the culture (the most common was Staphylococcus epidermidis), including 13 kinds of Gram-positive bacteria, 12 kinds of Gram-negative bacteria, and 4 kinds of funguses. All the antibiotics sensitivity results showed that the most sensitive antibiotics were vancomycin to Gram-positive bacteria (98.4%), levofloxacin to Gram-negative bacteria (68.5%), and fluconazole to fungus (83.3%). Univariate and multivariate analysis revealed the infection independent risk factors as follow: intraoperative blood loss ≥ 350 mL (P = 0.019), ascites volume ≥ 300 mL (P = 0.008).
PMP patients may have increased infection risk after CRS + HIPEC, especially CVC, abdominal-pelvic and pulmonary infections. The microbial spectrum and antibiotics sensitivity results could help clinicians to take prompt prophylactic and therapeutic approaches against postoperative infection for PMP patients.
细胞减灭术(CRS)加腹腔热灌注化疗(HIPEC)是假性黏液瘤腹膜病(PMP)的标准治疗方法。它可以显著延长患者的生存时间,但同时也可能增加术后感染的风险。
回顾性分析在我院行 CRS+HIPEC 的 PMP 患者。根据 PMP 患者的基本临床资料和术后感染的相关信息,分析术后感染的常见部位、微生物培养结果和抗生素敏感性。采用单因素和多因素分析探讨感染相关的危险因素。
在 482 例 PMP 患者中,82 例(17.0%)患者在 CRS+HIPEC 后发生感染。最常见的术后感染是中心静脉导管(CVC)感染(8.1%),其次是腹部-盆腔感染(5.2%)。从培养物中分离出 29 种微生物(最常见的是表皮葡萄球菌),包括 13 种革兰氏阳性菌、12 种革兰氏阴性菌和 4 种真菌。所有抗生素敏感性结果显示,对革兰氏阳性菌最敏感的抗生素是万古霉素(98.4%),对革兰氏阴性菌最敏感的抗生素是左氧氟沙星(68.5%),对真菌最敏感的抗生素是氟康唑(83.3%)。单因素和多因素分析显示,感染的独立危险因素为术中出血量≥350 mL(P=0.019)和腹水体积≥300 mL(P=0.008)。
PMP 患者在接受 CRS+HIPEC 后可能会增加感染风险,尤其是 CVC、腹部-盆腔和肺部感染。微生物谱和抗生素敏感性结果有助于临床医生为 PMP 患者采取及时的预防和治疗措施来应对术后感染。